IRADIMED CEO linked trust sells 7,500 shares
IRADIMED CORP director and CEO Roger E. Susi reported indirect open‑market sales of a total of 7,500 shares of common stock by the Phillip Susi 2008 Dynasty Trust on May 4–5, 2026, at prices including $87.31 and $83.78 per share.
Rhea-AI Filing Summary
IRADIMED CORP director and CEO Roger E. Susi reported indirect open‑market sales of a total of 7,500 shares of common stock by the Phillip Susi 2008 Dynasty Trust on May 4–5, 2026, at prices including $87.31 and $83.78 per share.
The transactions were carried out under a Rule 10b5-1 trading plan adopted on November 5, 2025, indicating they were pre‑scheduled. The filing also reflects indirect holdings through additional family trusts, and Susi disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 7,500 shares
Net Sell
9 txns
Insider
Susi Roger E.
Role
CEO, President, Chairman
Sold
7,500 shs ($643K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 600 | $83.78 | $50K |
| Sale | Common Stock | 1,322 | $85.56 | $113K |
| Sale | Common Stock | 1,650 | $86.43 | $143K |
| Sale | Common Stock | 178 | $87.31 | $16K |
| Sale | Common Stock | 2,447 | $85.32 | $209K |
| Sale | Common Stock | 1,103 | $86.26 | $95K |
| Sale | Common Stock | 200 | $87.05 | $17K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,187,500 shares (Indirect, By Phillip Susi 2008 Dynasty Trust);
Common Stock — 162,950 shares (Indirect, By Roger E. Susi Revocable Trust);
Common Stock — 2,062,500 shares (Indirect, By Matthew Susi 2008 Dynasty Trust)
Footnotes (8)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $84.86 to $85.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $85.91 to $86.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $83.42 to $84.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $84.90 to $85.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $85.93 to $86.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $86.94 to $87.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold: 7,500 shares
Sample sale price: $87.31 per share
Sample sale price: $83.78 per share
+3 more
6 metrics
Shares sold
7,500 shares
Total open-market sales reported on May 4–5, 2026
Sample sale price
$87.31 per share
Common stock sale price on May 5, 2026
Sample sale price
$83.78 per share
Common stock sale price on May 5, 2026
Rule 10b5-1 plan adoption
November 5, 2025
Date the pre-set trading plan was adopted
Single transaction size
2,447 shares
Largest individual reported sale of common stock
Additional transaction size
1,650 shares
Another reported block of common stock sold
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, beneficial ownership, Section 16, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
beneficial ownership financial
"The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did IRMD’s Roger E. Susi report on this Form 4?
Roger E. Susi reported indirect sales totaling 7,500 IRMD shares. The shares of common stock were sold in multiple open‑market transactions by the Phillip Susi 2008 Dynasty Trust on May 4–5, 2026, at prices in the mid‑$80s per share.
Were the IRMD insider sales by Roger E. Susi pre-planned under a Rule 10b5-1 plan?
Yes. The filing states the sales followed a Rule 10b5-1 plan. A footnote explains the transactions were effected pursuant to a trading plan adopted by the reporting person on November 5, 2025, indicating they were pre‑scheduled rather than discretionary.
What do the weighted-average price footnotes mean in IRMD’s Form 4?
They show each sale was split across multiple trades within a price range. For several transactions, the Form 4 reports a weighted average sale price and notes that individual trade prices, within specified ranges, are available upon request to the SEC staff or shareholders.
AI-generated analysis. How Rhea-AI works. Not financial advice.
